OR WAIT null SECS
Emerging Evidence in the Treatment of Obesity
In this episode of MEDcast, Diana Isaacs and Natalie Bellini interview Dr. Ken Fujioka, an endocrine specialist, to discuss practice guidelines on obesity treatment and the evolution of anti-obesity medications over the last decade.
To watch the video series component of this episode, click here.
1:20 Obesity-associated metabolic disturbances
5:37 When to start medication for obesity
8:28 Metabolic pathways leading to weight gain
13:19 Long-term impact of weight fluctuations
16:07 GLP-1 agonists for weight loss
20:26 Insurance coverage for anti-obesity medications (AOMs)
24:50 Combining lifestyle changes with AOMs
26:27 ‘Super-responders’ to GLP-1 agonist therapies
30:51 Non-responders to GLP-1 agonist therapies
37:28 Comprehensive approach to weight management
